Alnylam Pharmaceuticals, Inc. (ALNY)
USD 238.78
(5.52%)
USD 238.78
(5.52%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.05 Billion USD | 9.34% |
| 2022 | 3.7 Billion USD | 21.26% |
| 2021 | 3.05 Billion USD | 27.78% |
| 2020 | 2.39 Billion USD | 149.97% |
| 2019 | 956.44 Million USD | 250.55% |
| 2018 | 272.83 Million USD | 19.51% |
| 2017 | 228.29 Million USD | -33.36% |
| 2016 | 342.58 Million USD | 181.28% |
| 2015 | 121.79 Million USD | -15.02% |
| 2014 | 143.32 Million USD | -4.56% |
| 2013 | 150.18 Million USD | -2.14% |
| 2012 | 153.46 Million USD | -6.38% |
| 2011 | 163.92 Million USD | -30.26% |
| 2010 | 235.03 Million USD | -22.54% |
| 2009 | 303.42 Million USD | -13.94% |
| 2008 | 352.55 Million USD | 19.66% |
| 2007 | 294.62 Million USD | 658.71% |
| 2006 | 38.83 Million USD | 6.19% |
| 2005 | 36.56 Million USD | 83.17% |
| 2004 | 19.96 Million USD | -67.74% |
| 2003 | 61.89 Million USD | 198.16% |
| 2002 | 20.75 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4.04 Billion USD | -0.17% |
| 2024 Q2 | 4.01 Billion USD | -0.77% |
| 2024 Q3 | 4.17 Billion USD | 3.99% |
| 2023 Q4 | 4.05 Billion USD | 1.14% |
| 2023 FY | 4.05 Billion USD | 9.34% |
| 2023 Q3 | 4 Billion USD | 5.1% |
| 2023 Q1 | 3.65 Billion USD | -1.44% |
| 2023 Q2 | 3.81 Billion USD | 4.36% |
| 2022 Q3 | 3.6 Billion USD | 14.22% |
| 2022 Q2 | 3.15 Billion USD | 4.02% |
| 2022 Q1 | 3.03 Billion USD | -0.74% |
| 2022 FY | 3.7 Billion USD | 21.26% |
| 2022 Q4 | 3.7 Billion USD | 2.82% |
| 2021 Q4 | 3.05 Billion USD | 12.47% |
| 2021 FY | 3.05 Billion USD | 27.78% |
| 2021 Q3 | 2.71 Billion USD | 2.27% |
| 2021 Q1 | 2.32 Billion USD | -2.58% |
| 2021 Q2 | 2.65 Billion USD | 14.04% |
| 2020 Q1 | 929.89 Million USD | -2.78% |
| 2020 Q2 | 1.97 Billion USD | 112.35% |
| 2020 Q3 | 2.09 Billion USD | 5.96% |
| 2020 Q4 | 2.39 Billion USD | 14.27% |
| 2020 FY | 2.39 Billion USD | 149.97% |
| 2019 Q1 | 467.01 Million USD | 71.17% |
| 2019 FY | 956.44 Million USD | 250.55% |
| 2019 Q4 | 956.44 Million USD | 2.34% |
| 2019 Q3 | 934.53 Million USD | -2.57% |
| 2019 Q2 | 959.21 Million USD | 105.39% |
| 2018 Q1 | 168.33 Million USD | -26.27% |
| 2018 Q2 | 168.58 Million USD | 0.15% |
| 2018 FY | 272.83 Million USD | 19.51% |
| 2018 Q4 | 272.83 Million USD | 38.12% |
| 2018 Q3 | 197.53 Million USD | 17.17% |
| 2017 Q3 | 299.44 Million USD | -3.81% |
| 2017 Q1 | 303.02 Million USD | -11.55% |
| 2017 FY | 228.29 Million USD | -33.36% |
| 2017 Q4 | 228.29 Million USD | -23.76% |
| 2017 Q2 | 311.31 Million USD | 2.74% |
| 2016 Q4 | 342.58 Million USD | 14.99% |
| 2016 Q3 | 297.94 Million USD | 5.03% |
| 2016 Q1 | 127.89 Million USD | 5.01% |
| 2016 Q2 | 283.68 Million USD | 121.8% |
| 2016 FY | 342.58 Million USD | 181.28% |
| 2015 Q2 | 122.16 Million USD | -7.65% |
| 2015 Q1 | 132.28 Million USD | -7.71% |
| 2015 Q3 | 114.54 Million USD | -6.24% |
| 2015 Q4 | 121.79 Million USD | 6.33% |
| 2015 FY | 121.79 Million USD | -15.02% |
| 2014 Q2 | 90.39 Million USD | -27.87% |
| 2014 Q4 | 143.32 Million USD | 75.05% |
| 2014 Q1 | 125.32 Million USD | -16.55% |
| 2014 FY | 143.32 Million USD | -4.56% |
| 2014 Q3 | 81.87 Million USD | -9.42% |
| 2013 Q3 | 149.92 Million USD | -2.89% |
| 2013 Q4 | 150.18 Million USD | 0.17% |
| 2013 FY | 150.18 Million USD | -2.14% |
| 2013 Q1 | 160.02 Million USD | 4.27% |
| 2013 Q2 | 154.38 Million USD | -3.52% |
| 2012 Q1 | 142.91 Million USD | -12.81% |
| 2012 FY | 153.46 Million USD | -6.38% |
| 2012 Q4 | 153.46 Million USD | 5.7% |
| 2012 Q3 | 145.19 Million USD | 11.52% |
| 2012 Q2 | 130.19 Million USD | -8.91% |
| 2011 Q4 | 163.92 Million USD | -10.11% |
| 2011 FY | 163.92 Million USD | -30.26% |
| 2011 Q3 | 182.35 Million USD | -10.73% |
| 2011 Q2 | 204.27 Million USD | -8.59% |
| 2011 Q1 | 223.48 Million USD | -4.91% |
| 2010 Q3 | 251.96 Million USD | -8.28% |
| 2010 Q1 | 291.57 Million USD | -3.9% |
| 2010 Q2 | 274.7 Million USD | -5.79% |
| 2010 FY | 235.03 Million USD | -22.54% |
| 2010 Q4 | 235.03 Million USD | -6.72% |
| 2009 Q1 | 355.78 Million USD | 0.92% |
| 2009 Q3 | 313.64 Million USD | -6.14% |
| 2009 Q4 | 303.42 Million USD | -3.26% |
| 2009 Q2 | 334.17 Million USD | -6.08% |
| 2009 FY | 303.42 Million USD | -13.94% |
| 2008 Q3 | 375.62 Million USD | -1.38% |
| 2008 Q4 | 352.55 Million USD | -6.14% |
| 2008 Q2 | 380.87 Million USD | 34.37% |
| 2008 Q1 | 283.44 Million USD | -3.79% |
| 2008 FY | 352.55 Million USD | 19.66% |
| 2007 FY | 294.62 Million USD | 658.71% |
| 2007 Q3 | 312.15 Million USD | 672.89% |
| 2007 Q2 | 40.38 Million USD | 8.24% |
| 2007 Q1 | 37.31 Million USD | -3.91% |
| 2007 Q4 | 294.62 Million USD | -5.62% |
| 2006 Q2 | 37.03 Million USD | 3.54% |
| 2006 Q3 | 39.75 Million USD | 7.33% |
| 2006 FY | 38.83 Million USD | 6.19% |
| 2006 Q1 | 35.77 Million USD | -2.18% |
| 2006 Q4 | 38.83 Million USD | -2.31% |
| 2005 Q4 | 36.56 Million USD | 81.24% |
| 2005 Q2 | 21.47 Million USD | 11.62% |
| 2005 Q1 | 19.23 Million USD | -3.64% |
| 2005 FY | 36.56 Million USD | 83.17% |
| 2005 Q3 | 20.17 Million USD | -6.04% |
| 2004 Q1 | 78.41 Million USD | 26.71% |
| 2004 FY | 19.96 Million USD | -67.74% |
| 2004 Q4 | 19.96 Million USD | 13.67% |
| 2004 Q3 | 17.56 Million USD | -1.31% |
| 2004 Q2 | 17.79 Million USD | -77.3% |
| 2003 Q4 | 61.89 Million USD | 0.0% |
| 2003 FY | 61.89 Million USD | 198.16% |
| 2002 FY | 20.75 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Caribou Biosciences, Inc. | 72.56 Million USD | -5481.771% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -114687.182% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -206982.004% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -10455.662% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -732.412% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -3007.732% |
| Agenus Inc. | 462.29 Million USD | -776.177% |
| Fortress Biotech, Inc. | 165.93 Million USD | -2340.972% |
| GlycoMimetics, Inc. | 6.9 Million USD | -58585.607% |
| Novavax, Inc. | 2.57 Billion USD | -57.469% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -10612.271% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -24806.376% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -8400.575% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -1685.693% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -1387.594% |
| AlloVir, Inc. | 45.01 Million USD | -8898.165% |
| Aptorum Group Limited | 5.25 Million USD | -76953.945% |
| Ardelyx, Inc. | 130.76 Million USD | -2997.607% |
| Bicycle Therapeutics plc | 224.41 Million USD | -1704.95% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -3010.763% |
| Chimerix, Inc. | 19.74 Million USD | -20414.176% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -11414.657% |
| CRISPR Therapeutics AG | 346.76 Million USD | -1068.079% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -8012.405% |
| Precision BioSciences, Inc. | 140.92 Million USD | -2774.343% |
| Dyadic International, Inc. | 2.34 Million USD | -172951.173% |
| Elevation Oncology, Inc. | 34.28 Million USD | -11715.308% |
| Fortress Biotech, Inc. | 165.93 Million USD | -2340.972% |
| GT Biopharma, Inc. | 6.63 Million USD | -60966.245% |
| Alkermes plc | 933.53 Million USD | -333.89% |
| Immix Biopharma, Inc. | 3.72 Million USD | -108732.89% |
| Innoviva, Inc. | 568.55 Million USD | -612.428% |
| IO Biotech, Inc. | 17.55 Million USD | -22972.021% |
| Jaguar Health, Inc. | 45.86 Million USD | -8731.213% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -2998.934% |
| ContextLogic Inc. | 206 Million USD | -1866.274% |
| AbCellera Biologics Inc. | 335.77 Million USD | -1106.317% |
| Lantern Pharma Inc. | 2.73 Million USD | -147746.502% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -165565.603% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -746.699% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -1622.059% |
| MEI Pharma, Inc. | 8.35 Million USD | -48380.239% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -14623.289% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -61203.965% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -2527.77% |
| NextCure, Inc. | 14.99 Million USD | -26908.895% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -5566.654% |
| ChromaDex Corporation | 26.5 Million USD | -15180.383% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -14250.329% |
| Incyte Corporation | 1.59 Billion USD | -154.387% |
| Opthea Limited | 264.6 Million USD | -1430.803% |
| MiMedx Group, Inc. | 96.33 Million USD | -4104.842% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -8566.262% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -14776.318% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -33362.41% |
| Vaxcyte, Inc. | 167.44 Million USD | -2318.96% |
| PDS Biotechnology Corporation | 33.25 Million USD | -12078.682% |
| Pharming Group N.V. | 244.07 Million USD | -1559.554% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -33875.206% |
| Onconetix, Inc. | 23.18 Million USD | -17373.55% |
| Acelyrin, Inc. | 86.35 Million USD | -4590.658% |
| PureTech Health plc | 125.58 Million USD | -3125.376% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -8334.726% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -3069.647% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -114681.913% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -61203.965% |
| ESSA Pharma Inc. | 3.49 Million USD | -115792.467% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -2676.823% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -100110.886% |
| Seer, Inc. | 39.36 Million USD | -10189.658% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -4813.717% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -28069.72% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -60874.319% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -311660.79% |
| Summit Therapeutics Inc. | 125.25 Million USD | -3133.771% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -42631.554% |
| Senti Biosciences, Inc. | 52.57 Million USD | -7604.864% |
| ImmuCell Corporation | 18.81 Million USD | -21428.135% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -2573.401% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -11133.357% |
| Precigen, Inc. | 41.64 Million USD | -9626.549% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -41341.825% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -60563.831% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -5789.358% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -1065.35% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -303181.909% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -719.1% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -6450.642% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -43142.49% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -45157.251% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -13860.103% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -1680.881% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -2839.422% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -37013.102% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -1432.026% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -4720.56% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -14808.624% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -125467.546% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -5390.97% |
| Aptose Biosciences Inc. | 15.8 Million USD | -25522.118% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -36590.573% |
| Soligenix, Inc. | 7.27 Million USD | -55578.041% |
| Century Therapeutics, Inc. | 175.94 Million USD | -2202.206% |
| Kura Oncology, Inc. | 51.66 Million USD | -7740.432% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -3239.757% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -97904.452% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -61143.012% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -1503.546% |
| Autolus Therapeutics plc | 263.9 Million USD | -1434.83% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -38542.664% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -4458.27% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -8536.696% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -1047.925% |
| GRI Bio, Inc. | 2.69 Million USD | -150086.281% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -500221.029% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -12927.963% |
| IGM Biosciences, Inc. | 220.17 Million USD | -1739.667% |
| INmune Bio, Inc. | 18.86 Million USD | -21374.52% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -1479.281% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -15103.636% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -148903.644% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -123381.571% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -6829.303% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -4112.319% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -1430.03% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -392.148% |
| Verastem, Inc. | 71.18 Million USD | -5590.137% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -8136.79% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -10399.57% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -8177.863% |
| Histogen Inc. | 5.69 Million USD | -70999.245% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -92259.526% |
| Surrozen, Inc. | 8.14 Million USD | -49630.19% |
| Organovo Holdings, Inc. | 2.74 Million USD | -147298.981% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1290459.425% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -7103.506% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -24430.79% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -7826.196% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -489759.289% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -3096.31% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -37357.718% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -2584.44% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -155250.519% |
| Apollomics, Inc. | 14.15 Million USD | -28519.544% |
| Amarin Corporation plc | 279.58 Million USD | -1348.753% |
| Mesoblast Limited | 188.79 Million USD | -2045.427% |
| Turnstone Biologics Corp. | 14.14 Million USD | -28529.658% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -2140.483% |
| Synaptogenix, Inc. | 5.52 Million USD | -73153.399% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -60828.46% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -2281.148% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -47234.728% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -230384.815% |
| Exelixis, Inc. | 678.44 Million USD | -497.031% |
| Better Therapeutics, Inc. | 23.84 Million USD | -16889.028% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -2369.139% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -581.667% |
| NLS Pharmaceutics AG | 10.68 Million USD | -37825.53% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -249375.492% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -10305.436% |
| Gritstone bio, Inc. | 125.91 Million USD | -3116.77% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -27499.646% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -79499.546% |
| Avid Bioservices, Inc. | 275.66 Million USD | -1369.349% |
| Insmed Incorporated | 1.66 Billion USD | -143.749% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -52545.066% |
| MediWound Ltd. | 27.18 Million USD | -14798.753% |
| OmniAb, Inc. | 87.4 Million USD | -4534.467% |
| Alector, Inc. | 487.66 Million USD | -730.589% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -903.957% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -21883.848% |
| Zai Lab Limited | 240.17 Million USD | -1586.475% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -542.881% |
| Aura Biosciences, Inc. | 29.22 Million USD | -13758.843% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -4160.256% |
| Immunic, Inc. | 25.36 Million USD | -15867.061% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -5750.315% |
| Veracyte, Inc. | 93.71 Million USD | -4221.988% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -154696.721% |
| FibroGen, Inc. | 585.72 Million USD | -591.537% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -23201.64% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -620122.455% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -71521.503% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 47.096% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -49308.685% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -4720.79% |
| TG Therapeutics, Inc. | 169.08 Million USD | -2295.555% |
| Galecto, Inc. | 5.89 Million USD | -68599.525% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -48795.751% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -54.695% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -13953.584% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -31993.527% |
| XBiotech Inc. | 8.39 Million USD | -48137.752% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -27499.646% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -7516.63% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1015.521% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -14966.672% |
| Theravance Biopharma, Inc. | 169 Million USD | -2296.703% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -233.212% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -709.415% |
| Vaxxinity, Inc. | 30.94 Million USD | -12989.853% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -316.511% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -67060.54% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -443.524% |
| NexImmune, Inc. | 5.08 Million USD | -79568.355% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -1090527.205% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -131630.869% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 43.007% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -78489.453% |
| Scopus BioPharma Inc. | 7.45 Million USD | -54237.11% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -15304.746% |
| Ainos, Inc. | 7.39 Million USD | -54679.576% |
| Pluri Inc. | 34.11 Million USD | -11774.191% |
| Prothena Corporation plc | 135.01 Million USD | -2900.01% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -1566.176% |
| Celularity Inc. | 102.92 Million USD | -3835.26% |
| Rallybio Corporation | 9.43 Million USD | -42826.282% |
| Cue Biopharma, Inc. | 24.44 Million USD | -16469.949% |
| MeiraGTx Holdings plc | 319.99 Million USD | -1165.824% |
| Omeros Corporation | 403.25 Million USD | -904.465% |
| Humacyte, Inc. | 114.67 Million USD | -3432.115% |
| Immunocore Holdings plc | 228.15 Million USD | -1675.315% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -82987.672% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -5178.243% |
| Blueprint Medicines Corporation | 918.64 Million USD | -340.926% |
| CalciMedica, Inc. | 4.02 Million USD | -100459.186% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -23109.512% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -4619.955% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -1358.109% |
| Pulmatrix, Inc. | 15.96 Million USD | -25274.453% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -25580.112% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -16361.53% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -1514.99% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -7875.669% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -234.577% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -12644.31% |
| Nutriband Inc. | 1.07 Million USD | -375324.29% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -37993.896% |
| Vor Biopharma Inc. | 59.1 Million USD | -6753.215% |
| Roivant Sciences Ltd. | 773.95 Million USD | -423.355% |
| Evogene Ltd. | 17.99 Million USD | -22415.42% |
| ProKidney Corp. | 29.21 Million USD | -13764.061% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -5527.369% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -574456.266% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -114.437% |
| CorMedix Inc. | 11.91 Million USD | -33887.955% |
| BioLineRx Ltd. | 50.7 Million USD | -7888.884% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -2610.124% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -4479.917% |
| Atai Life Sciences N.V. | 49.16 Million USD | -8139.136% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -12902.325% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -22450.518% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -3149.883% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -71539.972% |
| MediciNova, Inc. | 3.89 Million USD | -103985.027% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -22059.44% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -269173.607% |
| GeoVax Labs, Inc. | 3.51 Million USD | -114975.595% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -919.618% |
| Biomea Fusion, Inc. | 30.69 Million USD | -13098.188% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -48.821% |
| Mereo BioPharma Group plc | 15.96 Million USD | -25276.043% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -12882.033% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -6802.263% |
| Absci Corporation | 58.3 Million USD | -6847.249% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -21164.826% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -12533.411% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -5389.259% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -4530.07% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -11894.445% |
| Allakos Inc. | 74.79 Million USD | -5315.646% |
| Imunon, Inc. | 8.53 Million USD | -47383.25% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -17901.529% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -3427.962% |
| BioAtla, Inc. | 48.98 Million USD | -8168.738% |
| NLS Pharmaceutics AG | 10.68 Million USD | -37825.53% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -145654.732% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -3001.378% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -28394.717% |
| XOMA Corporation | 145.58 Million USD | -2682.335% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -11931.855% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -5790.9% |
| aTyr Pharma, Inc. | 31.59 Million USD | -12719.331% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -6451.808% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -8908.171% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -8268.505% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -141033.24% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -49550.834% |
| Akari Therapeutics, Plc | 4.58 Million USD | -88262.216% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -22741.563% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -145.566% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1002733.318% |
| UroGen Pharma Ltd. | 243.52 Million USD | -1563.302% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -1161.504% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -146575.319% |
| Orgenesis Inc. | 35.53 Million USD | -11298.689% |
| Entera Bio Ltd. | 1.37 Million USD | -293629.079% |
| GH Research PLC | 6.7 Million USD | -60346.56% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -59466.529% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -21415.585% |
| Xencor, Inc. | 283.55 Million USD | -1328.459% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -135565.268% |
| Replimune Group, Inc. | 113.21 Million USD | -3477.759% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -107709.136% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -3812.416% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1002733.318% |
| Portage Biotech Inc. | 4.45 Million USD | -90923.011% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -269173.607% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -17472.772% |
| OncoCyte Corporation | 49.29 Million USD | -8116.406% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -97814.308% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -507812.886% |
| Purple Biotech Ltd. | 10 Million USD | -40384.998% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -69905.6% |
| scPharmaceuticals Inc. | 57.26 Million USD | -6973.792% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -32597.103% |
| HilleVax, Inc. | 78.9 Million USD | -5033.158% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -80108.396% |
| Tharimmune, Inc. | 1.81 Million USD | -223063.71% |
| Genprex, Inc. | 3.25 Million USD | -124370.347% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -14836.111% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -77259.129% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -1966173.786% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -1129602.02% |
| OKYO Pharma Limited | 7.42 Million USD | -54483.049% |
| Savara Inc. | 37.19 Million USD | -10790.847% |
| Curis, Inc. | 57.61 Million USD | -6930.695% |
| Daré Bioscience, Inc. | 26.32 Million USD | -15283.769% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -10233.024% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -280407.202% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -19355.901% |
| BeiGene, Ltd. | 2.23 Billion USD | -81.333% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -18925.655% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -1443.662% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -18939.786% |
| Erasca, Inc. | 78.61 Million USD | -5052.617% |
| bluebird bio, Inc. | 424.62 Million USD | -853.908% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -618062.783% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -114.307% |
| DBV Technologies S.A. | 42.8 Million USD | -9363.841% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -618062.783% |
| Moderna, Inc. | 4.57 Billion USD | 11.406% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -57805.99% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -244496.86% |
| Molecular Templates, Inc. | 31.17 Million USD | -12894.527% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -23628.905% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -588.744% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -3153.302% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -14662.999% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -11010.72% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -7180.532% |
| MacroGenics, Inc. | 154.2 Million USD | -2526.68% |
| RenovoRx, Inc. | 4.46 Million USD | -90596.91% |
| Adicet Bio, Inc. | 37.12 Million USD | -10811.972% |
| Prime Medicine, Inc. | 60.78 Million USD | -6564.238% |
| Aditxt, Inc. | 28.53 Million USD | -14096.645% |
| Adagene Inc. | 45.16 Million USD | -8867.419% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2241461.474% |
| Quantum-Si incorporated | 26.63 Million USD | -15109.808% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -480.665% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -133034.151% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -3423.39% |
| SciSparc Ltd. | 1.59 Million USD | -253851.348% |
| Vericel Corporation | 127.7 Million USD | -3071.782% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -72687.083% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -4645.33% |
| Generation Bio Co. | 171.63 Million USD | -2260.033% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -34969.472% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -9583.068% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -1502.911% |
| Invivyd, Inc. | 51.71 Million USD | -7732.7% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -4303.844% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -62165.453% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -5265.217% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -396621.254% |
| 2seventy bio, Inc. | 310.12 Million USD | -1206.09% |
| ADMA Biologics, Inc. | 193.97 Million USD | -1988.157% |
| Clene Inc. | 38.95 Million USD | -10299.024% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -11110.084% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -1476.227% |
| GeoVax Labs, Inc. | 3.51 Million USD | -114975.595% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -2028.908% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -33156.457% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -1942.398% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -33115.174% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -8319.122% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -7565.495% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -995.168% |
| Evaxion Biotech A/S | 17.61 Million USD | -22891.506% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -2416.963% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -2544.187% |
| Trevena, Inc. | 48.26 Million USD | -8292.781% |
| Surrozen, Inc. | 8.14 Million USD | -49630.19% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -18656.768% |
| Cingulate Inc. | 10.36 Million USD | -38994.458% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -147191.782% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -10761.643% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -112837.444% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -30702.464% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -1176.958% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -16200.551% |
| Clearmind Medicine Inc. | 3.61 Million USD | -112102.632% |
| Kronos Bio, Inc. | 54.2 Million USD | -7373.154% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -8510.259% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -17696.888% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -20080.978% |
| Statera Biopharma, Inc. | 22.67 Million USD | -17762.247% |
| ImmunityBio, Inc. | 1.09 Billion USD | -271.475% |
| Korro Bio, Inc. | 51.75 Million USD | -7726.797% |
| Kineta, Inc. | 7.22 Million USD | -55985.904% |
| BioVie Inc. | 9.7 Million USD | -41648.812% |
| Codexis, Inc. | 49.94 Million USD | -8009.807% |
| Celularity Inc. | 102.92 Million USD | -3835.26% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -4108.468% |
| Celcuity Inc. | 51.45 Million USD | -7772.727% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -1173305.1% |
| Cibus, Inc. | 206.11 Million USD | -1865.158% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -9436.254% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -15278.427% |
| IN8bio, Inc. | 8.77 Million USD | -46075.604% |
| Kodiak Sciences Inc. | 213.59 Million USD | -1796.393% |
| Annexon, Inc. | 47.11 Million USD | -8496.553% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -4423.653% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -4103.009% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -29489.627% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -55.587% |
| Eyenovia, Inc. | 19.78 Million USD | -20377.587% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -2187.32% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -52634.331% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -16707.851% |
| Arcellx, Inc. | 339.75 Million USD | -1092.2% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -33943.738% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -1549.639% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -42256.206% |
| Moolec Science SA | 13.94 Million USD | -28945.684% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -9286.643% |
| Geron Corporation | 146.12 Million USD | -2671.92% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -7915.76% |
| Royalty Pharma plc | 6.29 Billion USD | 35.681% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -10083.337% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -1375729.297% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -164536.574% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -2041.367% |
| Humacyte, Inc. | 114.67 Million USD | -3432.115% |
| Structure Therapeutics Inc. | 29.05 Million USD | -13842.802% |
| 89bio, Inc. | 59.96 Million USD | -6655.039% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -15206.367% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -338572.575% |
| Genelux Corporation | 8.42 Million USD | -48005.986% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -58979.988% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -2871.357% |
| Notable Labs, Ltd. | 4.42 Million USD | -91395.911% |
| Liquidia Corporation | 73.13 Million USD | -5438.194% |
| Mustang Bio, Inc. | 17.61 Million USD | -22889.523% |
| Immunovant, Inc. | 48.95 Million USD | -8173.974% |
| Quantum-Si incorporated | 26.63 Million USD | -15109.808% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -10452.911% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -130435.74% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -5383.982% |
| Acasti Pharma Inc. | 11.55 Million USD | -34948.231% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -17816.544% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -148903.644% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -10883.876% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -297111.562% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -66345.604% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -16209.74% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -17371.204% |
| PepGen Inc. | 34.63 Million USD | -11596.237% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -33254.117% |
| United Therapeutics Corporation | 1.18 Billion USD | -242.626% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -57897.194% |
| Solid Biosciences Inc. | 38.45 Million USD | -10432.331% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -47234.728% |
| Immuneering Corporation | 12 Million USD | -33630.882% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -1290459.425% |
| Silo Pharma, Inc. | 1.56 Million USD | -258015.175% |
| Belite Bio, Inc | 4.21 Million USD | -96089.124% |
| XOMA Corporation | 145.58 Million USD | -2682.335% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -166725.535% |
| Bionomics Limited | 10.15 Million USD | -39772.382% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -18747.536% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -17577.842% |
| uniQure N.V. | 624.01 Million USD | -549.103% |
| Cassava Sciences, Inc. | 14.19 Million USD | -28434.864% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -2241461.474% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -2280.085% |
| Forte Biosciences, Inc. | 3.66 Million USD | -110388.925% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -1554308.384% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -59934.445% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -52634.331% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -23201.64% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -38228.198% |
| Altimmune, Inc. | 16.54 Million USD | -24387.782% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -555.737% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -17577.842% |
| Compugen Ltd. | 55.77 Million USD | -7162.257% |
| Peak Bio, Inc. | 20.75 Million USD | -19417.433% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -3566.86% |
| Benitec Biopharma Inc. | 4.96 Million USD | -81530.875% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -2466.173% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -5288.198% |
| Zura Bio Limited | 21.29 Million USD | -18923.69% |
| PolyPid Ltd. | 17.46 Million USD | -23088.253% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -3503.701% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -5288.198% |
| Instil Bio, Inc. | 99.8 Million USD | -3958.601% |
| argenx SE | 444.95 Million USD | -810.33% |
| Immunome, Inc. | 28.65 Million USD | -14034.008% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -48484.911% |
| Verona Pharma plc | 58.84 Million USD | -6783.846% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -27886.762% |
| Shattuck Labs, Inc. | 14.85 Million USD | -27159.735% |
| CervoMed Inc. | 2.59 Million USD | -155944.638% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -83004.719% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -31703.737% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -38348.258% |
| Moolec Science SA | 13.94 Million USD | -28945.684% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -172740.499% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -7185.732% |
| AnaptysBio, Inc. | 364.28 Million USD | -1011.908% |
| Design Therapeutics, Inc. | 11.95 Million USD | -33778.588% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -31834.122% |
| NeurAxis, Inc. | 1.91 Million USD | -211665.641% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -10305.169% |
| Lumos Pharma, Inc. | 13.33 Million USD | -30279.689% |
| Achilles Therapeutics plc | 19.08 Million USD | -21121.376% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -27886.762% |
| 180 Life Sciences Corp. | 5.38 Million USD | -75087.801% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -17071.976% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -17696.888% |
| Nutriband Inc. | 1.07 Million USD | -375324.29% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -13137.872% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -27813.473% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -909.416% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -12373.513% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -30940.648% |
| Palisade Bio, Inc. | 2.73 Million USD | -147783.315% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -77008.776% |
| Beam Therapeutics Inc. | 478.38 Million USD | -746.708% |
| Neurogene Inc. | 36.54 Million USD | -10982.448% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -917.845% |
| AEON Biopharma, Inc. | 159.88 Million USD | -2433.335% |
| Sesen Bio, Inc. | 30.98 Million USD | -12972.954% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -15502.342% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -53180.833% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -1969.36% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -2009.022% |
| Athira Pharma, Inc. | 30.05 Million USD | -13376.142% |
| Vaccinex, Inc. | 5.94 Million USD | -68067.688% |
| HCW Biologics Inc. | 15.05 Million USD | -26810.307% |
| XOMA Corporation | 145.58 Million USD | -2682.335% |
| Nektar Therapeutics | 267.04 Million USD | -1416.789% |
| Arvinas, Inc. | 644.6 Million USD | -528.378% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -22741.563% |
| Merus N.V. | 102.15 Million USD | -3865.232% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -2667.697% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -4158.331% |
| Rezolute, Inc. | 11.73 Million USD | -34419.55% |
| Clene Inc. | 38.95 Million USD | -10299.024% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -142154.423% |
| BeyondSpring Inc. | 48.26 Million USD | -8291.564% |
| Synlogic, Inc. | 32.89 Million USD | -12213.494% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -27618.634% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -247790.086% |
| Peak Bio, Inc. | 20.75 Million USD | -19417.433% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -6282.899% |
| Krystal Biotech, Inc. | 39.71 Million USD | -10099.235% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -975.425% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -3968.057% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -935948.215% |
| MannKind Corporation | 721.36 Million USD | -461.507% |
| Ikena Oncology, Inc. | 22.33 Million USD | -18035.321% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -194076.606% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -3848.264% |
| Gossamer Bio, Inc. | 249.14 Million USD | -1525.757% |
| CohBar, Inc. | 1.03 Million USD | -391770.655% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -37794.321% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -21164.826% |
| Legend Biotech Corporation | 589.93 Million USD | -586.607% |
| Mural Oncology plc | 37.92 Million USD | -10579.509% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -2953.865% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -176367.892% |
| Disc Medicine, Inc. | 22.87 Million USD | -17607.209% |
| Champions Oncology, Inc. | 28.03 Million USD | -14348.097% |
| REGENXBIO Inc. | 262.22 Million USD | -1444.657% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -120474.563% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -32216.292% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -30056.615% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -19001.74% |
| Vaxart, Inc. | 34.02 Million USD | -11804.553% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -19765.965% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -14096.484% |
| Cellectis S.A. | 249.57 Million USD | -1522.969% |
| Longeveron Inc. | 5.33 Million USD | -75795.147% |
| Repare Therapeutics Inc. | 41.81 Million USD | -9585.846% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -68.404% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -6609.72% |
| Revolution Medicines, Inc. | 262.39 Million USD | -1443.662% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -192141.291% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -46857.153% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -34223.566% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -28743.723% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -188208.88% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 21.346% |
| Denali Therapeutics Inc. | 122.96 Million USD | -3194.1% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -72687.083% |
| Veru Inc. | 32.81 Million USD | -12244.377% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -58868.176% |
| Cingulate Inc. | 10.36 Million USD | -38994.458% |
| Passage Bio, Inc. | 39.26 Million USD | -10216.652% |
| Context Therapeutics Inc. | 4.19 Million USD | -96531.665% |
| Exicure, Inc. | 8.54 Million USD | -47280.091% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -13626.867% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -38527.923% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -18277.224% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -2385.198% |
| Nuvalent, Inc. | 31.82 Million USD | -12628.291% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -63571.196% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -6327.159% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -22402.911% |
| OmniAb, Inc. | 87.4 Million USD | -4534.467% |
| Anew Medical, Inc. | 8.24 Million USD | -49046.115% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -10478.793% |
| Lipocine Inc. | 2.63 Million USD | -153816.984% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -15317.646% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -9972.924% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -15103.636% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -4601.493% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -74895.816% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -4795.071% |
| Ocugen, Inc. | 23.98 Million USD | -16789.146% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -8628.261% |
| Q32 Bio Inc. | 233.12 Million USD | -1637.468% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -44578.182% |
| Alumis Inc. Common Stock | 53.5 Million USD | -7470.79% |
| Equillium, Inc. | 27.95 Million USD | -14388.407% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -1860.639% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -71888.007% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -65945.086% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -2474.606% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -5733.716% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -40510.01% |
| Dominari Holdings Inc. | 4.63 Million USD | -87289.946% |
| Edesa Biotech, Inc. | 1.84 Million USD | -219841.498% |
| vTv Therapeutics Inc. | 29.56 Million USD | -13599.476% |
| Bio-Techne Corporation | 744.34 Million USD | -444.177% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -3112.178% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -1075.919% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -9882.807% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -13888.065% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -4285.583% |
| Nkarta, Inc. | 105.6 Million USD | -3735.723% |
| BioCardia, Inc. | 4.59 Million USD | -88146.71% |
| Iterum Therapeutics plc | 32.66 Million USD | -12301.335% |